Press release
Antihypertensive Drugs Market Expected to Witness the Highest Growth during 2020-2027 With: Pfizer, Novartis AG, Sanofi, LUPIN and AstraZeneca
Antihypertensive Drugs Market
Antihypertensive drugs are used to treat hypertension and to prevent the complication of high blood pressure. Hypertension is a medical condition where the blood pressure in the arteries is persistently high. High blood pressure increases the risk of heart failure, ischaemic heart diseases stroke, and death. Hypertension also leads to some other problems such as renal impairment, visual impairment and retinal hemorrhage. Antihypertensive drugs are consumed by the patients (once a day) in a low dose. However. side effects associated with these drugs are usually minor.
The antihypertensive drugs market is expected to grow in coming years owing to factors such as increase in number of patients suffering from hypertension, change in lifestyle such as food habits, increasing penetration of generic versions of drugs and growing prevalence of chronic diseases. Also the launch of novel drug therapy with improved efficacy and safety and patent expiration of blockbuster drug has offered new opportunities for market growth.
Get PDF Sample Copy of this Report @ http://bit.ly/2w9DCyj
Top Leading Market Players:
1. Pfizer Inc.
2. Novartis AG
3. Sanofi.
4. Merck & Co. , Inc.
5. Boehringer Ingelheim International GmbH.
6. LUPIN.
7. Johnson & Johnson Services, Inc.
8. AstraZeneca
9. DAIICHI SANKYO COMPANY, LIMITED.
10. Ranbaxy Laboratories Limited, Inc.
Market Segmentation :
The global antihypertensive drugs market is segmented on the basis of therapeutics and distribution channel. Based on therapeutics, the market is segmented as diuretics, angiotensin receptor blockers (ARBS), angiotensin converting enzyme (ACE) inhibitors, beta blockers, alpha blockers, calcium channel blockers, renin inhibitors and vasodilators. Based on distribution channel the antihypertensive drugs market is segmented as hospital pharmacy, retail pharmacy, e-commerce websites and online drug stores.
Key Benefits= :
To provide detailed information regarding the major factors (drivers, restraints, opportunities, challenges, and trends) influencing the growth of the global Antihypertensive Drugs Market.
To forecast the size of the market segments with respect to four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (Latin America and the Middle East & Africa).
The Antihypertensive Drugs Market report is a combination of qualitative as well as quantitative analysis which can be broken down into 40% and 60% respectively. Market estimation and forecasts are presented in the report for the overall global market from 2018 - 2027, considering 2018 as the base year and 2018 - 2027 forecast period. Global estimation is further broken down by segments and geographies such as North America, Europe, Asia-Pacific, Middle East & Africa and South America covering major 18 countries across the mentioned regions.
The qualitative contents for geographical analysis will cover market trends in each region and country which includes highlights of the key players operating in the respective region/country, PEST analysis of each region which includes political, economic, social and technological factors influencing the growth of the market.
Browse market data tables and in-depth TOC of the Global Antihypertensive Drugs Market (2019-2027)
Purchase for Report @ http://bit.ly/2Ubv2qK
Reasons to Buy the Report :
Learn about the driving factors, affecting the market growth.
Imbibe the advancements and progress in the market during the forecast period.
Understand where the market opportunities lies.
Compare and evaluate various options affecting the market.
Pick up on the leading market players within the market.
Envision the restrictions and restrains that are likely to hamper the market.
Contact Us:
The Insight partners,
Phone: +1-646-491-9876
Email: sales@theinsightpartners.com
Website: www.theinsightpartners.com
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antihypertensive Drugs Market Expected to Witness the Highest Growth during 2020-2027 With: Pfizer, Novartis AG, Sanofi, LUPIN and AstraZeneca here
News-ID: 1967998 • Views: …
More Releases from The Insight Partners
Future of Clean Energy - Complete Guide (PDF)
With the mounting population and industrialization, the demand for energy is also rising at the global level. This has boosted the need for alternative energy sources, as traditional energy resources such as fossil fuels are directing to environmental pollution. Clean alternative options such as solar and wind curb immense carbon emissions and their negative impact on the environment and help balance the energy supply and demand. Thus, the rise in…
Mechanical Thrombectomy Devices Market Size, Demand, Share, Analysis with Focus …
An off-the-shelf report on Mechanical Thrombectomy Devices Market which has been compiled after an in-depth analysis of the market trends prevailing across five geographies (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). Various segments of the market such as type/components/ application/industry verticals/ end-users are analyzed with robust research methodology which includes three step process starting with extensive secondary research to gather data from company profiles, global/regional associations, trade…
Containment Piping System Market Size, Demand, Analytical Overview, Comprehensiv …
Containment Piping System Market study by "The Insight Partners" provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years. This Report encloses comprehensive analysis on the market and are assessed through volume and value data validated on three approaches including top companies' revenues. It concludes with precise and…
Nutraceuticals - An Ultimate PDF Guide
Consumers in developed and some developing countries are highly attracted to functional products, mainly on account of the added health and wellness benefits. Nutraceuticals are associated with various medicinal and health benefits, such as to improve the function of the immune system, boost gut health, and others. Rising healthcare costs, coupled with the increasing geriatric population across the world, propels the adoption of various nutraceuticals such as dietary supplements, functional…
More Releases for Antihypertensive
Antihypertensive Drugs Market Future Prediction Report By 2033
The global Antihypertensive Drugs Market was valued at approximately USD 30.5 billion in 2024 and is projected to reach around USD 38.4 billion by 2033, growing at a compound annual growth rate (CAGR) of 2.6% from 2025 to 2033 .
Antihypertensive Drugs Market Overview
The global Antihypertensive Drugs Marke is driven by the rising global burden of hypertension, especially among the elderly and individuals with lifestyle-related risk factors such as obesity, poor…
Antihypertensive Drugs Market Segmentation, and Future Growth Prospects
In recent years, the global Antihypertensive Drugs Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Antihypertensive Drugs Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including Porters Five…
Antihypertensive Drugs Market Size to Reach USD 10 Billion 2030
Exclusive Report by Ameco Research: Antihypertensive Drugs Market Size Projected to Reach USD 52 Billion by 2030, Growing at 4.70% CAGR
Ameco Research is proud to announce the launch of its latest market research report, Antihypertensive Drugs Market. This comprehensive report provides in-depth analysis and insights into the current market trends and future projections in the Industry/Market Segment. Ameco Research has been at the forefront of providing quality market research…
Antihypertensive Drugs Market to Develop Rapidly by 2031, TMR Study
The global Antihypertensive Drugs Market market is estimated to attain a valuation of US$ 40 Bn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 3% during the forecast period, 2022 to 2031.
The key objective of the TMR report is to offer a complete assessment of the global market including major…
Global Antihypertensive Drugs Market Study Analysis: Hypertension is becoming ev …
The fast-food market size was valued at $ billion in 2020 and is estimated to reach $ billion by 2028, growing at a CAGR of 4.87% during the forecast period. Hypertension is a medical condition that results in a rise in blood pressure in the arteries. Hypertension may lead to numerous serious complications including heart failure, aneurysm, heart attacks, and dementia. To prevent the serious effects of hypertension early diagnosis…
Safety And Effectiveness Of First-line Antihypertensive Drug Classes
For those with extremely high blood pressure, or hypertension, there are many initial medication options -- so many that it can be hard to know which one to use. Now, a Yale-coauthored paper in Lancet provides more information about the relative safety and effectiveness of different hypertension drugs in order to inform this critical treatment decision. The study reveals that angiotensin converting enzyme (ACE) inhibitors may not be the best…
